These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8681261)

  • 1. The clozapine experience from a family perspective.
    Dickson RA; Williams R; Dalby JT
    Can J Psychiatry; 1995 Dec; 40(10):627-9. PubMed ID: 8681261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
    Meltzer HY; Cola P; Way L; Thompson PA; Bastani B; Davies MA; Snitz B
    Am J Psychiatry; 1993 Nov; 150(11):1630-8. PubMed ID: 8105705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine, cytokines, fever and sleep].
    Hinze-Selch D; Mullington J; Pollmächer T
    Wien Med Wochenschr; 1996; 146(13-14):311-3. PubMed ID: 9012164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Families' perspectives of clozapine treatment.
    Stebbin HT
    Perspect Psychiatr Care; 1995; 31(4):14-8; quiz 19-20. PubMed ID: 8552464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clozapine in the treatment of schizophrenia].
    Raitasuo V
    Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Jurgis G; Perlick D; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 Sep; 61(9):671-6. PubMed ID: 11030488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Rather overweight and mentally present...". Patients evaluate clozapine].
    Boitz K; Angermeyer MC; Löffler W; Müller P; Priebe S
    Psychiatr Prax; 1999 Jul; 26(4):188-93. PubMed ID: 10457971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients.
    Rechlin T; Beck G; Weis M; Kaschka WP
    Psychopharmacology (Berl); 1998 Feb; 135(4):338-41. PubMed ID: 9539257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms.
    Jones H; Curtis VA; Wright P; Lucey JV
    Am J Psychiatry; 1998 Jun; 155(6):838-40. PubMed ID: 9619161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased psychopathology & family burden. Associated with clozapine treatment of patients with refractory schizophrenia.
    Snyder N; Goldstein G
    J Psychosoc Nurs Ment Health Serv; 2002 May; 40(5):34-9. PubMed ID: 12016691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment.
    Ahn YM; Chang JS; Kim Y; Lee KY; Kim JH; Kim SC; Maeng SJ; Kim YS
    Int Clin Psychopharmacol; 2005 May; 20(3):157-61. PubMed ID: 15812266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine.
    Kumar S; Ng B; Howie W
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):235-6. PubMed ID: 12667173
    [No Abstract]   [Full Text] [Related]  

  • 17. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
    J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine and recidivism.
    Gordon BJ; Milke DJ
    Psychiatr Serv; 1995 Oct; 46(10):1079. PubMed ID: 8829795
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
    Zipris P; Melamed Y; Weizman A; Bleich A
    Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.